Results 191 to 200 of about 61,036 (213)

Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii

Clinical Microbiology and Infection, 2004
Ja Young Choi, Young Goo Song, Yong Dongeun   +2 more
exaly  

Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections

Pharmacotherapy, 2020
Kimberly C Claeys, Jordan Smith, Jeffrey M Rybak   +2 more
exaly  

Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections

International Journal of Infectious Diseases, 2008
Hürrem Bodur
exaly  

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2018
Elizabeth Rhee, Sheng Bi, Mark H Gotfried   +2 more
exaly  

Imipenem

Reactions Weekly, 2001
openaire   +1 more source

Imipenem

2007
openaire   +1 more source

Imipenem

2021
openaire   +1 more source

Imipenem

Reactions Weekly, 2011
openaire   +2 more sources

Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males

European Journal of Clinical Microbiology and Infectious Diseases, 1991
I Nilsson-Ehle, S R Norrby
exaly  

Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii

International Journal of Antimicrobial Agents, 2012
Han-Yueh Kuo, Kai-Chih Chang, Ming-Li Liou   +2 more
exaly